MGMT and glioblastoma: Management strategies for GBM can be multidisciplinary combinations, including those that inhibit the proliferation of cancer stem cells, downregulate the expression of MGMT to resensitize cells to TMZ, convert an immunosuppressive cold microenvironment to a hot one, and activate exogenous immune cells after systemic administration of a promising drug candidate.